Literature DB >> 18922079

Use of a serum (1-->3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis jiroveci pneumonia.

María Soledad Cuétara, Almudena Alhambra, Fernando Chaves, María Dolores Moragues, José Pontón, Amalia del Palacio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18922079     DOI： 10.1086/592753

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  10 in total

1.  Serum (1->3)-{beta}-D-Glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia.

Authors:  Amalia Del Palacio; Maria Soledad Cuétara; Jara Llenas-García; Maria Elena Alvarez; Fernando Chaves; Federico Pulido; Mercedes Catalán; José Pontón; Valerio Del Bono; Claudio Viscoli
Journal:  Clin Vaccine Immunol       Date:  2010-01

2.  Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Authors:  J Acosta; M Catalan; A del Palacio-Pérez-Medel; J-C Montejo; J De-La-Cruz-Bértolo; M-D Moragues; J Pontón; M A Finkelman; A del Palacio
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-08-03       Impact factor: 3.267

3.  Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.

Authors:  Céline Damiani; Solène Le Gal; Cécilia Da Costa; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

4.  Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia.

Authors:  Tobias Lahmer; Clarissa Prazeres da Costa; Jürgen Held; Sebastian Rasch; Ursula Ehmer; Roland M Schmid; Wolfgang Huber
Journal:  Mycopathologia       Date:  2017-04-04       Impact factor: 2.574

5.  Serum (1->3)-beta-D-glucan levels in primary infection and pulmonary colonization with Pneumocystis jirovecii.

Authors:  Céline Damiani; Solène Le Gal; Delphine Lejeune; Naima Brahimi; Michèle Virmaux; Gilles Nevez; Anne Totet
Journal:  J Clin Microbiol       Date:  2011-03-23       Impact factor: 5.948

6.  Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.

Authors:  Michael J Linke; Alan Ashbaugh; Margaret S Collins; Keeley Lynch; Melanie T Cushion
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

7.  Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.

Authors:  Stefanie Desmet; Eric Van Wijngaerden; Johan Maertens; Jan Verhaegen; Eric Verbeken; Paul De Munter; Wouter Meersseman; Britt Van Meensel; Johan Van Eldere; Katrien Lagrou
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

8.  Diagnosis of pneumocystis pneumonia using serum (1-3)-β-D-Glucan: a bivariate meta-analysis and systematic review.

Authors:  Wei-Jie Li; Ya-Ling Guo; Tang-Juan Liu; Ke Wang; Jin-Liang Kong
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

9.  Pneumocystis Jirovecii Pneumonia Diagnosis via Metagenomic Next-Generation Sequencing.

Authors:  Xiaoxiao Lu; Jianhui Zhang; Wentao Ma; Lihua Xing; Hanbing Ning; Mengying Yao
Journal:  Front Med (Lausanne)       Date:  2022-03-09

10.  Diagnostic accuracy of (1→3)-β-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients.

Authors:  Petra Rogina; Miha Skvarc
Journal:  Radiol Oncol       Date:  2020-05-28       Impact factor: 2.991
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.